Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

QTRX

Quanterix Corp

Apr 25 • 11:02AM ET

15.66

Dollar change -0.38
Percentage change -2.37	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB VTWO VHT SCHA DFAS DFAT

Index	RUT	P/E	-	EPS (ttm)	-0.86	Insider Own	9.52%	Shs Outstand	38.01M	Perf Week	-0.82%
Market Cap	598.99M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	-0.10%	Shs Float	34.61M	Perf Month	-28.49%
Income	-32.33M	PEG	-	EPS next Q	-0.31	Inst Own	83.23%	Short Float	3.20%	Perf Quarter	-33.02%
Sales	122.37M	P/S	4.89	EPS this Y	-15.93%	Inst Trans	-7.37%	Short Ratio	3.07	Perf Half Y	-28.62%
Book/sh	9.13	P/B	1.72	EPS next Y	9.78%	ROA	-7.41%	Short Interest	1.11M	Perf Year	34.19%
Cash/sh	8.40	P/C	1.86	EPS next 5Y	-	ROE	-9.16%	52W Range	11.39 - 29.70	Perf YTD	-42.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.72%	ROI	-8.42%	52W High	-47.27%	Beta	1.40
Dividend TTM	-	Quick Ratio	9.26	Sales past 5Y	28.48%	Gross Margin	54.70%	52W Low	37.49%	ATR (14)	1.15
Dividend Ex-Date	-	Current Ratio	9.84	EPS Y/Y TTM	67.16%	Oper. Margin	-41.56%	RSI (14)	22.20	Volatility	5.80% 5.86%
Employees	441	Debt/Eq	0.12	Sales Y/Y TTM	15.96%	Profit Margin	-26.42%	Recom	1.40	Target Price	29.80
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	34.58%	Payout	-	Rel Volume	0.54	Prev Close	16.04
Sales Surprise	5.70%	EPS Surprise	-5.10%	Sales Q/Q	22.17%	Earnings	Feb 29 AMC	Avg Volume	360.41K	Price	15.66
SMA20	-19.21%	SMA50	-32.33%	SMA200	-34.50%	Trades		Volume	53,243	Change	-2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
05:10PM	Loading…
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
04:00PM	Loading…
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire)
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)
04:50PM	Quanterix Releases Operating Results for Third Quarter 202 (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate National Vision (EYE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-30-23 04:00PM	Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire)
Oct-24-23 04:30PM	Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimers Disease (Business Wire) +10.36%
Oct-23-23 08:30PM	Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection (Business Wire)
Oct-03-23 12:36PM	Quanterix (QTRX): A Closer Look at Its Modestly Undervalued Status (GuruFocus.com)
Sep-29-23 08:32AM	Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes (Zacks)
Sep-28-23 05:00PM	Quanterix CEO to Speak at Goldman Sachs Alzheimers Disease Day (Business Wire)
10:37AM	Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales (Zacks)
09:45AM	Loading…
09:45AM	Quanterix Corporation (QTRX) Moves 7.2% Higher: Will This Strength Last? (Zacks)
Sep-27-23 11:40AM	Quanterix Corp (QTRX): An In-Depth Look at Its Undervalued Status (GuruFocus.com) +7.16%
07:51AM	Here's Why Investors Should Retain STERIS (STE) Stock for Now (Zacks)
07:47AM	Here's Why You Should Buy Align Technology (ALGN) Stock Now (Zacks)
Sep-21-23 09:42AM	Here's Why Investors Should Buy Alcon (ALC) Stock Right Now (Zacks)
Sep-15-23 08:21AM	Here's Why You Should Retain Insulet (PODD) Stock for Now (Zacks)
Sep-13-23 08:16AM	Here's Why You Should Invest in Edward Lifesciences (EW) Now (Zacks)
Sep-06-23 10:04AM	Here's Why You Should Retain Omnicell (OMCL) Stock Now (Zacks)
09:48AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Sep-05-23 08:00AM	Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-31-23 08:37AM	Here's Why You Should Retain Integra (IART) Stock for Now (Zacks)
Aug-30-23 09:32AM	Here's Why You Should Retain Zimmer Biomet (ZBH) for Now (Zacks)
Aug-25-23 10:26AM	Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth (Zacks)
09:34AM	BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model (Zacks)
09:14AM	Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch (Zacks)
09:04AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)
Aug-21-23 04:30PM	William P. Donnelly Appointed to Quanterixs Board of Directors (Business Wire)
Aug-09-23 08:30AM	Quanterix Appoints Vandana Sriram as Chief Financial Officer (Business Wire)
Aug-07-23 07:40PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.03%
05:13PM	Quanterix Releases Operating Results for Second Quarter 2023 (Business Wire)
Aug-03-23 08:00AM	Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference (Business Wire) -5.68%
Jul-31-23 08:00AM	Quanterixs Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients (Business Wire) +6.43%
Jul-26-23 11:29AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation (Simply Wall St.)
Jul-20-23 08:00AM	Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023 (Business Wire)
Jul-10-23 11:08AM	Quanterix (QTRX) Advances in Alzheimer's Diagnosis With LucentAD (Zacks)
02:01AM	Quanterix Corporation (QTRX) Surges 13.6%: Is This an Indication of Further Gains? (Zacks)
Jul-06-23 05:37PM	Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimers Disease in Patients (Business Wire)
Jun-29-23 09:35AM	Bullish Quanterix Insiders Loaded Up On US$5.6m Of Stock (Simply Wall St.)
Jun-07-23 04:00PM	Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference (Business Wire)
May-24-23 02:27AM	4 big analyst picks: Sherwin-Williams a buy at Jefferies on firming housing market (Investing.com)
May-16-23 11:01AM	Shareholders in Quanterix (NASDAQ:QTRX) are in the red if they invested three years ago (Simply Wall St.)
May-10-23 06:52AM	Q1 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
May-09-23 05:15PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for First Quarter 2023 (Business Wire)
May-04-23 11:20AM	Quanterix Corporation (QTRX) Soars 33.7%: Is Further Upside Left in the Stock? (Zacks) +12.13%
May-02-23 04:30PM	Quanterixs First Quarter 2023 Earnings Conference Call (Business Wire)
Apr-25-23 04:30PM	FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials (Business Wire) -7.23%
Apr-17-23 08:20AM	Investors Holding Back On Quanterix Corporation (NASDAQ:QTRX) (Simply Wall St.)
Mar-08-23 04:30PM	Quanterix to Participate in Barclays Global Healthcare Conference (Business Wire)
07:21AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 12:42AM	Q4 2022 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) -5.52%
Mar-06-23 09:35AM	Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +12.13%
08:09AM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations (Business Wire)
Feb-28-23 04:30PM	Quanterix to Present at Cowens 43rd Annual Health Care Conference (Business Wire)
Feb-27-23 02:03PM	Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call (Business Wire)
Feb-16-23 10:13AM	We're Not Very Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Rate (Simply Wall St.)
Jan-20-23 08:20AM	Bullish Quanterix Corporation (NASDAQ:QTRX) insiders filled their treasuries with US$5.6m worth of stock over last year (Simply Wall St.)
Jan-09-23 04:30PM	Quanterix Announces Appointment of Brian Blaser to Board of Directors (Business Wire)
08:30AM	Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test (Business Wire)
Jan-03-23 04:00PM	Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference (Business Wire) -7.15%
Dec-05-22 04:36PM	Quanterixs Simoa® Technology Drives Advances in Alzheimers Disease Research Presented at 2022 Clinical Trials on Alzheimers Disease (CTAD) Conference (Business Wire)
Nov-16-22 04:30PM	Quanterix to Participate in the 15th Clinical Trials on Alzheimers Disease (CTAD) Task Force (Business Wire)
Nov-10-22 04:30PM	Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +24.02%
06:13AM	Quanterix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-08-22 05:15PM	Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Corporation Releases Operating Results for Third Quarter 2022 (Business Wire)
Nov-01-22 04:30PM	Quanterix Third Quarter 2022 Earnings Conference Call (Business Wire)
Sep-09-22 10:34AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation (Simply Wall St.) +8.49%
Sep-07-22 09:55AM	Wall Street Analysts Predict a 73% Upside in Quanterix Corporation (QTRX): Here's What You Should Know (Zacks) +9.35%
Aug-22-22 11:45AM	Quanterix Corp - Insiders Are Buying Near All-Time Lows (GuruFocus.com)
Aug-13-22 08:37AM	Insider Buying: The Quanterix Corporation (NASDAQ:QTRX) Independent Director Just Bought 1,498% More Shares (Simply Wall St.)
Aug-11-22 09:35AM	Quanterix Corporation (QTRX) Loses 53.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +18.69%
Aug-10-22 06:04PM	Why Quanterix Stock Bounced Back on Wednesday (Motley Fool) +14.75%
Aug-09-22 06:28PM	Why Quanterix Shares Plunged by Nearly 55% Today (Motley Fool) -54.76%
Aug-08-22 05:45PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.61%
04:02PM	Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors (Business Wire)
04:01PM	Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance (Business Wire)
Aug-03-22 04:30PM	Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference (Business Wire) +6.77%
09:07AM	Strength Seen in Quanterix Corporation (QTRX): Can Its 5.1% Jump Turn into More Strength? (Zacks)
Aug-01-22 04:30PM	Quanterix Second Quarter 2022 Earnings Conference Call (Business Wire) -5.07%

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OLSON LAURIE J	Director	Apr 01 '24	Option Exercise	12.86	1,000	12,860	16,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Apr 01 '24	Sale	23.50	1,000	23,500	15,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Feb 14 '24	Sale	24.35	1,500	36,525	15,238	Feb 15 05:52 PM
OLSON LAURIE J	Director	Jan 02 '24	Option Exercise	12.86	1,000	12,860	17,738	Jan 04 04:09 PM
OLSON LAURIE J	Director	Jan 02 '24	Sale	26.91	1,000	26,910	16,738	Jan 04 04:09 PM
DONNELLY WILLIAM P	Director	Sep 08 '23	Buy	24.85	20,200	501,978	28,438	Sep 11 04:07 PM
MEISTER PAUL M	Director	Jun 07 '23	Option Exercise	2.89	23,335	67,438	287,970	Jun 08 04:25 PM

Open in Screener

MASS

908 Devices Inc

Apr 25 • 11:02AM ET

5.49

Dollar change -0.13
Percentage change -2.31	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG VTI VGT IWM VXF IWN SCHA VTWO IWC DFAT

Index	RUT	P/E	-	EPS (ttm)	-1.13	Insider Own	27.56%	Shs Outstand	32.52M	Perf Week	-1.96%
Market Cap	180.68M	Forward P/E	-	EPS next Y	-1.13	Insider Trans	-0.71%	Shs Float	23.84M	Perf Month	-16.82%
Income	-36.40M	PEG	-	EPS next Q	-0.36	Inst Own	63.54%	Short Float	5.16%	Perf Quarter	-26.31%
Sales	50.23M	P/S	3.60	EPS this Y	-10.80%	Inst Trans	3.50%	Short Ratio	7.46	Perf Half Y	-0.54%
Book/sh	5.09	P/B	1.08	EPS next Y	9.74%	ROA	-16.34%	Short Interest	1.23M	Perf Year	-22.68%
Cash/sh	4.43	P/C	1.24	EPS next 5Y	-	ROE	-20.44%	52W Range	4.85 - 12.51	Perf YTD	-51.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-31.19%	ROI	-21.49%	52W High	-56.12%	Beta	1.01
Dividend TTM	-	Quick Ratio	7.04	Sales past 5Y	21.26%	Gross Margin	46.52%	52W Low	13.20%	ATR (14)	0.39
Dividend Ex-Date	-	Current Ratio	7.71	EPS Y/Y TTM	-6.07%	Oper. Margin	-84.42%	RSI (14)	33.47	Volatility	6.06% 6.53%
Employees	230	Debt/Eq	0.04	Sales Y/Y TTM	7.21%	Profit Margin	-72.47%	Recom	1.00	Target Price	15.33
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	25.75%	Payout	-	Rel Volume	0.59	Prev Close	5.62
Sales Surprise	1.38%	EPS Surprise	12.88%	Sales Q/Q	23.26%	Earnings	Mar 05 BMO	Avg Volume	164.88K	Price	5.49
SMA20	-12.20%	SMA50	-18.29%	SMA200	-21.27%	Trades		Volume	26,532	Change	-2.31%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-07-23	Initiated	Stephens	Overweight	$14
Oct-15-21	Resumed	Cowen	Outperform
Jan-12-21	Initiated	William Blair	Outperform
Jan-12-21	Initiated	SVB Leerink	Outperform	$70
Jan-12-21	Initiated	Stifel	Buy	$65
Jan-12-21	Initiated	Cowen	Outperform

Apr-23-24 07:00AM	908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024 (Business Wire)
Mar-12-24 07:00AM	908 Devices Trace Chemical Identification Technology Adopted by European Agencies (Business Wire) +5.41%
Mar-07-24 12:02PM	908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-05-24 07:33AM	908 Devices Inc (MASS) Reports Growth Amidst Industry Headwinds (GuruFocus.com)
07:00AM	908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook (Business Wire)
07:00AM	Loading…
Feb-29-24 07:00AM	908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares Fully Integrated Cell Therapy Manufacturing Platform (Business Wire)
Feb-22-24 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Feb-20-24 07:00AM	908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 (Business Wire)
Feb-02-24 11:01PM	908 Devices Inc CFO Griffith Joseph H. IV Sells 15,409 Shares (GuruFocus.com)
Dec-28-23 12:00PM	908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +22.99%
Dec-27-23 10:30AM	2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street (Motley Fool)
Dec-22-23 01:01PM	Chief Product Officer Christopher Brown Sells 20,000 Shares of 908 Devices Inc (GuruFocus.com)
Dec-19-23 09:55AM	How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39% (Zacks) +17.52%
Dec-18-23 05:34AM	3 Russell 2000 Stocks That Are About to Get Absolutely Crushed (InvestorPlace)
Nov-14-23 07:00AM	908 Devices Announces MX908 Integration Capabilities (Business Wire) +19.12%
03:37PM	Loading…
Nov-09-23 03:37PM	908 Devices Inc. (NASDAQ:MASS) Q3 2023 Earnings Call Transcript (Insider Monkey) -11.83%
Nov-07-23 08:14AM	908 Devices Inc (MASS) Reports 9% Decrease in Q3 2023 Revenue, Narrows Full-Year Outlook (GuruFocus.com)
07:00AM	908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook (Business Wire)
Nov-06-23 04:30PM	908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System (Business Wire) -10.18%
Oct-31-23 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire) +12.95%
Oct-24-23 04:30PM	908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device (Business Wire)
07:00AM	908 Devices to Report Third Quarter Financial Results on November 7, 2023 (Business Wire)
Sep-26-23 07:00AM	908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program (Business Wire)
Sep-18-23 07:00AM	908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters (Business Wire)
Sep-15-23 07:00AM	908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase (Business Wire)
Aug-26-23 07:50AM	3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street (Motley Fool)
Aug-08-23 09:15AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +22.01%
07:00AM	908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook (Business Wire)
Aug-07-23 07:00AM	908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program (Business Wire)
Jul-31-23 07:00AM	908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection (Business Wire) +9.26%
07:00AM	Loading…
Jul-25-23 07:00AM	908 Devices to Report Second Quarter Financial Results on August 8, 2023 (Business Wire)
Jul-16-23 08:42AM	Investors in 908 Devices (NASDAQ:MASS) have unfortunately lost 59% over the last year (Simply Wall St.)
Jul-13-23 05:42AM	908 Devices Inc. (MASS) Soars 8.5%: Is Further Upside Left in the Stock? (Zacks)
May-30-23 07:00AM	908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference (Business Wire)
May-23-23 09:54AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks) +16.65%
07:00AM	908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference (Business Wire)
May-09-23 08:25AM	908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.16%
07:00AM	908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook (Business Wire)
May-04-23 07:00AM	908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer (Business Wire) +7.33%
Apr-26-23 07:00AM	Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices REBEL At-line Analyzer (Business Wire)
Apr-25-23 07:00AM	908 Devices to Report First Quarter Financial Results on May 9, 2023 (Business Wire) -6.46%
Apr-18-23 11:14AM	Pinning Down 908 Devices Inc.'s (NASDAQ:MASS) P/S Is Difficult Right Now (Simply Wall St.)
Mar-08-23 02:22AM	Q4 2022 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 08:25AM	908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook (Business Wire)
Feb-27-23 06:05PM	ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -5.01%
Feb-21-23 07:00AM	908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference (Business Wire) -11.37%
Feb-14-23 07:00AM	908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023 (Business Wire)
Feb-07-23 01:37PM	908 Devices Is Well Positioned, Analyst Says While Initiating Coverage (Benzinga)
Feb-06-23 05:16AM	Strong week for 908 Devices (NASDAQ:MASS) shareholders doesn't alleviate pain of one-year loss (Simply Wall St.)
Jan-17-23 07:00AM	908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control (Business Wire) +8.95%
Dec-29-22 06:02AM	908 Devices Inc. (NASDAQ:MASS) Q3 2022 Earnings Call Transcript (Insider Monkey) +6.57%
Dec-07-22 07:00AM	MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail (Business Wire)
Nov-16-22 06:24AM	908 Devices Third Quarter 2022 Earnings: EPS Beats Expectations (Simply Wall St.)
Nov-14-22 11:44AM	Why 908 Devices Stock Is Sinking Today (Motley Fool) -22.05%
10:05AM	908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook (Business Wire)
Nov-10-22 07:00AM	908 Devices Records Strong Momentum in Life Sciences Sector (Business Wire) +25.29%
Nov-09-22 07:00AM	908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations (Business Wire) -9.45%
Nov-02-22 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire) -6.69%
Oct-19-22 07:00AM	908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire)
Oct-12-22 05:00PM	908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis (Business Wire)
Sep-29-22 07:50AM	Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock? (Zacks)
Aug-09-22 04:00PM	908 Devices Inc. (MASS) Q2 2022 Earnings Call Transcript (Motley Fool) -12.42%
08:45AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook (Business Wire)
07:00AM	908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics (Business Wire)
Jul-27-22 07:00AM	908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference (Business Wire) +6.48%
Jul-25-22 07:21AM	Even after rising 19% this past week, 908 Devices (NASDAQ:MASS) shareholders are still down 35% over the past year (Simply Wall St.)
Jul-19-22 07:00AM	908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022 (Business Wire) +11.23%
Jun-13-22 04:22PM	We Will Shine: Cathie Woods Optimism and Her 10 Most Ambitious Stock Picks (Insider Monkey)
Jun-02-22 07:00AM	908 Devices Showcases Technology for Accelerating Mass Spec Workflows in Presentations at ASMS (Business Wire)
May-26-22 07:00AM	908 Devices to Participate in the William Blair 42nd Annual Growth Stock Conference (Business Wire) +5.64%
May-11-22 02:30AM	908 Devices Inc. (MASS) Q1 2022 Earnings Call Transcript (Motley Fool) -23.59%
May-10-22 08:15AM	908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +14.40%
07:00AM	908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook (Business Wire)
May-09-22 07:00AM	908 Devices Advances MX908 Handheld Device Capabilities (Business Wire) -9.99%
May-03-22 07:00AM	908 Devices Partners with Key Biomanufacturing Innovation Center (Business Wire)
Apr-21-22 07:00AM	908 Devices and CPI Team on Cell Culture Media Optimization for Improved Process Control in Bioprocessing Applications (Business Wire)
Apr-12-22 05:37PM	10 Best Stocks to Buy Now According to Billionaire Nicholas Pritzkers Tao Capital (Insider Monkey)
07:00AM	908 Devices to Report First Quarter Financial Results on May 10, 2022 (Business Wire)
Mar-08-22 05:58PM	Why 908 Devices Stock Rocketed 15% Higher Today (Motley Fool) +15.06%
Mar-07-22 10:30PM	908 Devices Inc. (MASS) Q4 2021 Earnings Call Transcript (Motley Fool)
05:15PM	908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook (Business Wire)
Mar-02-22 04:30PM	908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to its Board of Directors (Business Wire)
Feb-15-22 07:00AM	908 Devices to Report Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022 (Business Wire) +5.19%
Feb-14-22 12:24PM	908 Devices (NASDAQ:MASS) shareholders have endured a 80% loss from investing in the stock a year ago (Simply Wall St.)
Feb-08-22 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Jan-21-22 11:37AM	15 Worst Stock Picks of Cathie Wood (Insider Monkey)
Jan-09-22 07:00PM	908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 (Business Wire)
Jan-07-22 07:00AM	908 Devices Announces GSK Purchases Fifth REBEL Cell Culture Media Analyzer (Business Wire)
Jan-04-22 05:00PM	908 Devices and U.S. Forest Service Announce Development Collaboration (Business Wire) -5.48%
Dec-23-21 01:38PM	MainStay VP Small Cap Growth Portfolio Buys Option Care Health Inc, Leslies Inc, Kratos Defense ... (GuruFocus.com)
Dec-22-21 09:16AM	Top 10 Stock Picks of Billionaire Nicholas Pritzker (Insider Monkey)
07:00AM	908 Devices Teams With World-Renowned Guardian Centers of Georgia for First Responder Training (Business Wire)
Nov-11-21 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Nov-10-21 07:40PM	908 Devices Announces Pricing of Public Offering (Business Wire)
Nov-08-21 04:15PM	908 Devices Announces Launch of Public Offering (Business Wire)
Nov-04-21 11:03PM	908 Devices Inc. (MASS) Q3 2021 Earnings Call Transcript (Motley Fool) +11.03%

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knopp Kevin J.	President and CEO	Apr 16 '24	Option Exercise	1.75	47,000	82,250	458,981	Apr 16 04:11 PM
Brown Christopher D.	Chief Product Officer	Apr 01 '24	Option Exercise	1.75	3,600	6,300	884,994	Apr 02 04:06 PM
Griffith Joseph H. IV	Chief Financial Officer	Mar 26 '24	Option Exercise	1.58	8,437	13,330	93,437	Mar 27 04:16 PM
Griffith Joseph H. IV	Chief Financial Officer	Feb 02 '24	Sale	7.09	9,711	68,873	80,000	Feb 02 07:10 PM
Knopp Kevin J.	President and CEO	Feb 01 '24	Sale	7.00	9,071	63,461	411,981	Feb 02 04:39 PM
Griffith Joseph H. IV	Chief Financial Officer	Feb 01 '24	Sale	7.00	5,698	39,892	89,711	Feb 02 07:10 PM
Turner Michael S.	Chief Legal & Admin Officer	Feb 01 '24	Sale	6.99	5,232	36,559	9,105	Feb 02 04:40 PM
Brown Christopher D.	Chief Product Officer	Feb 01 '24	Sale	7.01	3,957	27,730	886,394	Feb 02 04:37 PM
Griffith Joseph H. IV	Chief Financial Officer	Dec 28 '23	Sale	12.08	6,000	72,480	80,000	Jan 02 05:01 PM
Brown Christopher D.	Chief Product Officer	Dec 21 '23	Sale	9.12	7,370	67,214	877,905	Dec 21 04:46 PM
Brown Christopher D.	Chief Product Officer	Dec 20 '23	Sale	9.10	5,235	47,638	885,275	Dec 21 04:46 PM
Brown Christopher D.	Chief Product Officer	Dec 19 '23	Sale	9.08	7,395	67,147	890,510	Dec 21 04:46 PM
Griffith Joseph H. IV	Chief Financial Officer	Dec 19 '23	Sale	9.08	5,580	50,666	86,000	Dec 21 04:47 PM
Brown Christopher D.	Chief Product Officer	Jun 07 '23	Sale	10.03	4,470	44,834	897,905	Jun 09 04:17 PM
Knopp Kevin J.	President and CEO	Jun 05 '23	Option Exercise	1.75	28,500	49,875	396,348	Jun 05 04:07 PM
Knopp Kevin J.	President and CEO	May 23 '23	Sale	10.12	60,000	607,200	367,848	May 25 04:08 PM
Brown Christopher D.	Chief Technology Officer	May 23 '23	Sale	10.02	10,000	100,200	892,375	May 25 04:12 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

QTRX

Quanterix Corp

MASS

908 Devices Inc

Upgrade your FINVIZ experience